<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35593959</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1084</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>European radiology</Title><ISOAbbreviation>Eur Radiol</ISOAbbreviation></Journal><ArticleTitle>Iron-sensitive MR imaging of the primary motor cortex to differentiate hereditary spastic paraplegia from other motor neuron diseases.</ArticleTitle><Pagination><StartPage>8058</StartPage><EndPage>8064</EndPage><MedlinePgn>8058-8064</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00330-022-08865-6</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Hereditary spastic paraplegia (HSP) is a group of genetic neurodegenerative diseases characterised by upper motor neuron (UMN) impairment of the lower limbs. The differential diagnosis with primary lateral sclerosis (PLS) and amyotrophic lateral sclerosis (ALS) can be challenging. As microglial iron accumulation was reported in the primary motor cortex (PMC) of ALS cases, here we assessed the radiological appearance of the PMC in a cohort of HSP patients using iron-sensitive MR imaging and compared the PMC findings among HSP, PLS, and ALS patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We included 3-T MRI scans of 23 HSP patients, 7 PLS patients with lower limb onset, 8 ALS patients with lower limb and prevalent UMN onset (UMN-ALS), and 84 ALS patients with any other clinical picture. The PMC was visually rated on 3D T2*-weighted images as having normal signal intensity, mild hypointensity, or marked hypointensity, and differences in the frequency distribution of signal intensity among the diseases were investigated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The marked hypointensity in the PMC was visible in 3/22 HSP patients (14%), 7/7 PLS patients (100%), 6/8 UMN-ALS patients (75%), and 35/84 ALS patients (42%). The frequency distribution of normal signal intensity, mild hypointensity, and marked hypointensity in HSP patients was different than that in PLS, UMN-ALS, and ALS patients (p &lt; 0.01 in all cases).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Iron-sensitive imaging of the PMC could provide useful information in the diagnostic work - up of adult patients with a lower limb onset UMN syndrome, as the cortical hypointensity often seen in PLS and ALS cases is apparently rare in HSP patients.</AbstractText><AbstractText Label="KEY POINTS" NlmCategory="CONCLUSIONS">&#x2022; The T2* signal intensity of the primary motor cortex was investigated in patients with HSP, PLS with lower limb onset, and ALS with lower limb and prevalent UMN onset (UMN-ALS) using a clinical 3-T MRI sequence. &#x2022; Most HSP patients had normal signal intensity in the primary motor cortex (86%); on the contrary, all the PLS and the majority of UMN-ALS patients (75%) had marked cortical hypointensity. &#x2022; The T2*-weighted imaging of the primary motor cortex could provide useful information in the differential diagnosis of sporadic adult-onset UMN syndromes.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to European Society of Radiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Cosottini</LastName><ForeName>Mirco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Department of Translational Research on New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Donatelli</LastName><ForeName>Graziella</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5325-0746</Identifier><AffiliationInfo><Affiliation>Neuroradiology Unit, Azienda Ospedaliero-Universitaria Pisana, Via Paradisa 2, 56124, Pisa, Italy. graziella_donatelli@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Imago7 Research Foundation, Pisa, Italy. graziella_donatelli@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricca</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Molecular Medicine Unit, IRCCS Fondazione Stella Maris, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bianchi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frosini</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Medical Specialties, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montano</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Migaleddu</LastName><ForeName>Gianmichele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Azienda Ospedaliero-Universitaria Pisana, Via Paradisa 2, 56124, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Prete</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tessa</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Molecular Medicine Unit, IRCCS Fondazione Stella Maris, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecchi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Azienda Ospedaliero-Universitaria Pisana, Via Paradisa 2, 56124, Pisa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Imago7 Research Foundation, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Amelio</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Department of Translational Research on New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siciliano</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mancuso</LastName><ForeName>Michelangelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santorelli</LastName><ForeName>Filippo Maria</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Molecular Medicine Unit, IRCCS Fondazione Stella Maris, Pisa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur Radiol</MedlineTA><NlmUniqueID>9114774</NlmUniqueID><ISSNLinking>0938-7994</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>E1UOL152H7</RegistryNumber><NameOfSubstance UI="D007501">Iron</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur Radiol. 2022 Sep 8;:</RefSource><PMID Version="1">36074266</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015419" MajorTopicYN="Y">Spastic Paraplegia, Hereditary</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="Y">Motor Cortex</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007501" MajorTopicYN="N">Iron</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Hereditary spastic paraplegia</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Primary lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Primary motor cortex</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>20</Day><Hour>11</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35593959</ArticleId><ArticleId IdType="doi">10.1007/s00330-022-08865-6</ArticleId><ArticleId IdType="pii">10.1007/s00330-022-08865-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shribman S, Reid E, Crosby AH, Houlden H, Warner TT (2019) Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches. Lancet Neurol 18(12):1136&#x2013;1146</Citation><ArticleIdList><ArticleId IdType="pubmed">31377012</ArticleId></ArticleIdList></Reference><Reference><Citation>Murala S, Nagarajan E, Bollu PC (2021) Hereditary spastic paraplegia. Neurol Sci 42(3):883&#x2013;894</Citation><ArticleIdList><ArticleId IdType="pubmed">33439395</ArticleId></ArticleIdList></Reference><Reference><Citation>Saputra L, Kumar KR (2021) Challenges and controversies in the genetic diagnosis of hereditary spastic paraplegia. Curr Neurol Neurosci Rep 21(4):15. https://doi.org/10.1007/s11910-021-01099-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-021-01099-x</ArticleId><ArticleId IdType="pubmed">33646413</ArticleId><ArticleId IdType="pmc">7921051</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza PVS, de Rezende Pinto WBV, de Rezende Batistella GN, Bortholin T, Oliveira ASB (2017) Hereditary spastic paraplegia: clinical and genetic hallmarks. Cerebellum 16(2):525&#x2013;551</Citation><ArticleIdList><ArticleId IdType="pubmed">27271711</ArticleId></ArticleIdList></Reference><Reference><Citation>Deluca GC, Ebers GC, Esiri MM (2004) The extent of axonal loss in the long tracts in hereditary spastic paraplegia. Neuropathol Appl Neurobiol 30(6):576&#x2013;584</Citation><ArticleIdList><ArticleId IdType="pubmed">15540998</ArticleId></ArticleIdList></Reference><Reference><Citation>Salinas S, Proukakis C, Crosby A, Warner TT (2008) Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol 7(12):1127&#x2013;1138</Citation><ArticleIdList><ArticleId IdType="pubmed">19007737</ArticleId></ArticleIdList></Reference><Reference><Citation>Behan WM, Maia M (1974) Str&#xfc;mpell&#x2019;s familial spastic paraplegia: genetics and neuropathology. J Neurol Neurosurg Psychiatry 37(1):8&#x2013;20</Citation><ArticleIdList><ArticleId IdType="pubmed">4813430</ArticleId><ArticleId IdType="pmc">494557</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruyn RP (1992) The neuropathology of hereditary spastic paraparesis. Clin Neurol Neurosurg 94(Suppl):S16&#x2013;S18</Citation><ArticleIdList><ArticleId IdType="pubmed">1320499</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz GA, Liu CN (1956) Hereditary (familial) spastic paraplegia; further clinical and pathologic observations. AMA Arch Neurol Psychiatry 75(2):144&#x2013;162</Citation><ArticleIdList><ArticleId IdType="pubmed">13282534</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakabayashi K, Kobayashi H, Kawasaki S, Kondo H, Takahashi H (2001) Autosomal recessive spastic paraplegia with hypoplastic corpus callosum, multisystem degeneration and ubiquitinated eosinophilic granules. Acta Neuropathol 101(1):69&#x2013;73</Citation><ArticleIdList><ArticleId IdType="pubmed">11194944</ArticleId></ArticleIdList></Reference><Reference><Citation>Denora PS, Smets K, Zolfanelli F et al (2016) Motor neuron degeneration in spastic paraplegia 11 mimics amyotrophic lateral sclerosis lesions. Brain 139(Pt 6):1723&#x2013;1734</Citation><ArticleIdList><ArticleId IdType="pubmed">27016404</ArticleId><ArticleId IdType="pmc">5839621</ArticleId></ArticleIdList></Reference><Reference><Citation>White KD, Ince PG, Lusher M et al (2000) Clinical and pathologic findings in hereditary spastic paraparesis with spastin mutation. Neurology 55(1):89&#x2013;94</Citation><ArticleIdList><ArticleId IdType="pubmed">10891911</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink JK (2001) Progressive spastic paraparesis: hereditary spastic paraplegia and its relation to primary and amyotrophic lateral sclerosis. Semin Neurol 21(2):199&#x2013;207</Citation><ArticleIdList><ArticleId IdType="pubmed">11442328</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding AE (1981) Hereditary &#x2018;pure&#x2019; spastic paraplegia: a clinical and genetic study of 22 families. J Neurol Neurosurg Psychiatry 44(10):871&#x2013;883</Citation><ArticleIdList><ArticleId IdType="pubmed">7310405</ArticleId><ArticleId IdType="pmc">491171</ArticleId></ArticleIdList></Reference><Reference><Citation>Brugman F, Veldink JH, Franssen H et al (2009) Differentiation of hereditary spastic paraparesis from primary lateral sclerosis in sporadic adult-onset upper motor neuron syndromes. Arch Neurol 66(4):509&#x2013;514</Citation><ArticleIdList><ArticleId IdType="pubmed">19364936</ArticleId></ArticleIdList></Reference><Reference><Citation>Fullam T, Statland J (2021) Upper motor neuron disorders: primary lateral sclerosis, upper motor neuron dominant amyotrophic lateral sclerosis, and hereditary spastic paraplegia. Brain Sci 11(5):611. https://doi.org/10.3390/brainsci11050611</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11050611</ArticleId><ArticleId IdType="pubmed">34064596</ArticleId><ArticleId IdType="pmc">8151104</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Chi&#xf2; A, Cosottini M et al (2010) The present and the future of neuroimaging in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 31(10):1769&#x2013;1777</Citation><ArticleIdList><ArticleId IdType="pubmed">20360339</ArticleId><ArticleId IdType="pmc">7964007</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosottini M, Pesaresi I, Piazza S et al (2012) Structural and functional evaluation of cortical motor areas in amyotrophic lateral sclerosis. Exp Neurol 234(1):169&#x2013;180</Citation><ArticleIdList><ArticleId IdType="pubmed">22226599</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan JY, Jeong SY, Van Gelderen P et al (2012) Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One 7(4):e35241. https://doi.org/10.1371/journal.pone.0035241</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035241</ArticleId><ArticleId IdType="pubmed">22529995</ArticleId><ArticleId IdType="pmc">3328441</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosottini M, Donatelli G, Costagli M et al (2016) High-resolution 7T MR imaging of the motor cortex in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 37:455&#x2013;461</Citation><ArticleIdList><ArticleId IdType="pubmed">26680464</ArticleId><ArticleId IdType="pmc">7960124</ArticleId></ArticleIdList></Reference><Reference><Citation>Costagli M, Donatelli G, Biagi L et al (2016) Magnetic susceptibility in the deep layers of the primary motor cortex in amyotrophic lateral sclerosis. Neuroimage Clin 12:965&#x2013;969</Citation><ArticleIdList><ArticleId IdType="pubmed">27995062</ArticleId><ArticleId IdType="pmc">5153607</ArticleId></ArticleIdList></Reference><Reference><Citation>Donatelli G, Retico A, Caldarazzo Ienco E et al (2018) Semiautomated evaluation of the primary motor cortex in patients with amyotrophic lateral sclerosis at 3T. AJNR Am J Neuroradiol 39(1):63&#x2013;69</Citation><ArticleIdList><ArticleId IdType="pubmed">29122765</ArticleId><ArticleId IdType="pmc">7410679</ArticleId></ArticleIdList></Reference><Reference><Citation>Donatelli G, Caldarazzo Ienco E, Costagli M et al (2019) MRI cortical feature of bulbar impairment in patients with amyotrophic lateral sclerosis. Neuroimage Clin 24:101934. https://doi.org/10.1016/j.nicl.2019.101934</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.101934</ArticleId><ArticleId IdType="pubmed">31377555</ArticleId><ArticleId IdType="pmc">6698695</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi M, Agosta F, Abrahams S et al (2010) EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases. Eur J Neurol 17(4):526&#x2013;533</Citation><ArticleIdList><ArticleId IdType="pubmed">20136647</ArticleId><ArticleId IdType="pmc">3154636</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding AE (1983) Classification of the hereditary ataxias and paraplegias. Lancet 1(8334):1151&#x2013;1155</Citation><ArticleIdList><ArticleId IdType="pubmed">6133167</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;le R, Holland-Letz T, Klimpe S et al (2006) The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity. Neurology 67(3):430&#x2013;434</Citation><ArticleIdList><ArticleId IdType="pubmed">16894103</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Barohn RJ, Corcia P et al (2020) Primary lateral sclerosis: consensus diagnostic criteria. J Neurol Neurosurg Psychiatry 91:373&#x2013;377</Citation><ArticleIdList><ArticleId IdType="pubmed">32029539</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293&#x2013;299</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS Functional Rating Scale that incorporates assessments of respiratory function. BDNF ALS Study Group (phase III). J Neurol Sci 169(1-2):13&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159&#x2013;174</Citation><ArticleIdList><ArticleId IdType="pubmed">843571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hope ACA (1968) A simplified Monte Carlo significance test procedure. J R Stat Soc Series B 30:582&#x2013;598</Citation></Reference><Reference><Citation>Strong MJ, Gordon PH (2005) Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis: discrete entities or spectrum? Amyotroph Lateral Scler Other Motor Neuron Disord 6(1):8&#x2013;16</Citation><ArticleIdList><ArticleId IdType="pubmed">16036421</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, Cheng B, Katz IB et al (2006) The natural history of primary lateral sclerosis. Neurology 66(5):647&#x2013;653</Citation><ArticleIdList><ArticleId IdType="pubmed">16534101</ArticleId></ArticleIdList></Reference><Reference><Citation>Gozutok O, Helmold BR, Ozdinler PH (2021) Mutations and protein interaction landscape reveal key cellular events perturbed in upper motor neurons with HSP and PLS. Brain Sci 11(5):578. https://doi.org/10.3390/brainsci11050578</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11050578</ArticleId><ArticleId IdType="pubmed">33947096</ArticleId><ArticleId IdType="pmc">8146506</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay-Sim A (2021) Hereditary spastic paraplegia: from genes, cells and networks to novel pathways for drug discovery. Brain Sci 11(3):403. https://doi.org/10.3390/brainsci11030403</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11030403</ArticleId><ArticleId IdType="pubmed">33810178</ArticleId><ArticleId IdType="pmc">8004882</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink JK (2013) Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol 126(3):307&#x2013;328</Citation><ArticleIdList><ArticleId IdType="pubmed">23897027</ArticleId><ArticleId IdType="pmc">4045499</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki SO, Iwaki T, Arakawa K, Furuya H, Fujii N, Iwaki A (2011) An autopsy case of adult-onset hereditary spastic paraplegia type 2 with a novel mutation in exon 7 of the proteolipid protein 1 gene. Acta Neuropathol 122(6):775&#x2013;781</Citation><ArticleIdList><ArticleId IdType="pubmed">22101368</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Scarlato M, Spinelli EG et al (2015) Hereditary spastic paraplegia: beyond clinical phenotypes toward a unified pattern of central nervous system damage. Radiology 276(1):207&#x2013;218</Citation><ArticleIdList><ArticleId IdType="pubmed">25611737</ArticleId></ArticleIdList></Reference><Reference><Citation>da Gra&#xe7;a FF, de Rezende TJR, Vasconcellos LFR, Pedroso JL, Barsottini OGP, Fran&#xe7;a MC Jr (2019) Neuroimaging in hereditary spastic paraplegias: current use and future perspectives. Front Neurol 9:1117. https://doi.org/10.3389/fneur.2018.01117</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01117</ArticleId><ArticleId IdType="pubmed">30713518</ArticleId><ArticleId IdType="pmc">6346681</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindig T, Bender B, Hauser TK et al (2015) Gray and white matter alterations in hereditary spastic paraplegia type SPG4 and clinical correlations. J Neurol 262(8):1961&#x2013;1971</Citation><ArticleIdList><ArticleId IdType="pubmed">26050637</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince PG, Evans J, Knopp M et al (2003) Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 60(8):1252&#x2013;1258</Citation><ArticleIdList><ArticleId IdType="pubmed">12707426</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Robberecht W (2011) Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol 10(3):253&#x2013;263</Citation><ArticleIdList><ArticleId IdType="pubmed">21349440</ArticleId></ArticleIdList></Reference><Reference><Citation>Riad SM, Hathout H, Huang JC (2011) High T2 signal in primary lateral sclerosis supports the topographic distribution of fibers in the corpus callosum: assessing disease in the primary motor segment. AJNR Am J Neuroradiol 32(4):E61&#x2013;E64</Citation><ArticleIdList><ArticleId IdType="pubmed">20299433</ArticleId><ArticleId IdType="pmc">7965866</ArticleId></ArticleIdList></Reference><Reference><Citation>Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC (1992) Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 115(Pt2):495&#x2013;520</Citation><ArticleIdList><ArticleId IdType="pubmed">1606479</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CF, Kakita A, Piao YS et al (2003) Primary lateral sclerosis: a rare upper-motor-predominant form of amyotrophic lateral sclerosis often accompanied by frontotemporal lobar degeneration with ubiquitinated neuronal inclusions? Report of an autopsy case and a review of the literature. Acta Neuropathol 105(6):615&#x2013;620</Citation><ArticleIdList><ArticleId IdType="pubmed">12734667</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson DW, Josephs KA, Amador-Ortiz C (2007) TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol 114(1):71&#x2013;79</Citation><ArticleIdList><ArticleId IdType="pubmed">17569066</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal MF, Richardson EP Jr (1981) Primary lateral sclerosis: a case report. Arch Neurol 38(10):630&#x2013;633</Citation><ArticleIdList><ArticleId IdType="pubmed">7295106</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe R, Iino M, Honda M, Sane J, Hara M (1997) Primary lateral sclerosis. Neuropathology 17:220&#x2013;224</Citation></Reference><Reference><Citation>Paganoni S, Alshikho MJ, Z&#xfc;rcher NR et al (2017) Imaging of glia activation in people with primary lateral sclerosis. Neuroimage Clin 17:347&#x2013;353</Citation><ArticleIdList><ArticleId IdType="pubmed">29159046</ArticleId><ArticleId IdType="pmc">5681341</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA (2020) Neuropathology of primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 21(sup1):47&#x2013;51</Citation><ArticleIdList><ArticleId IdType="pubmed">33602010</ArticleId></ArticleIdList></Reference><Reference><Citation>de Bot ST, van den Elzen RTM, Mensenkamp AR et al (2010) Hereditary spastic paraplegia due to SPAST mutations in 151 Dutch patients: new clinical aspects and 27 novel mutations. J Neurol Neurosurg Psychiatry 81(10):1073&#x2013;1078</Citation><ArticleIdList><ArticleId IdType="pubmed">20562464</ArticleId></ArticleIdList></Reference><Reference><Citation>Magariello A, Muglia M, Patitucci A et al (2010) Mutation analysis of the SPG4 gene in Italian patients with pure and complicated forms of spastic paraplegia. J Neurol Sci 288(1-2):96&#x2013;100</Citation><ArticleIdList><ArticleId IdType="pubmed">19875132</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amore A, Tessa A, Casali C et al (2018) Next generation molecular diagnosis of hereditary spastic paraplegias: an Italian cross-sectional study. Front Neurol 9:981. https://doi.org/10.3389/fneur.2018.00981</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00981</ArticleId><ArticleId IdType="pubmed">30564185</ArticleId><ArticleId IdType="pmc">6289125</ArticleId></ArticleIdList></Reference><Reference><Citation>Brugman F, Wokke JH, Scheffer H, Versteeg MH, Sistermans EA, van den Berg LH (2005) Spastin mutations in sporadic adult-onset upper motor neuron syndromes. Ann Neurol 58(6):865&#x2013;869</Citation><ArticleIdList><ArticleId IdType="pubmed">16240363</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Deignan JL, Dorrani N et al (2014) Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA 312(18):1880&#x2013;1887</Citation><ArticleIdList><ArticleId IdType="pubmed">25326637</ArticleId><ArticleId IdType="pmc">4278636</ArticleId></ArticleIdList></Reference><Reference><Citation>DaRe JT, Vasta V, Penn J, Tran N-T B, Hahn SH (2013) Targeted exome sequencing for mitochondrial disorders reveals high genetic heterogeneity. BMC Med Genet 14:118. https://doi.org/10.1186/1471-2350-14-118</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2350-14-118</ArticleId><ArticleId IdType="pubmed">24215330</ArticleId><ArticleId IdType="pmc">3827825</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X, Madireddy L, Caillier S (2018) Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis. Ann Neurol 84(1):51&#x2013;63</Citation><ArticleIdList><ArticleId IdType="pubmed">29908077</ArticleId><ArticleId IdType="pmc">6119489</ArticleId></ArticleIdList></Reference><Reference><Citation>Balicza P, Varga N&#xc1;, Bolg&#xe1;r B et al (2019) Comprehensive analysis of rare variants of 101 autism-linked genes in a Hungarian cohort of autism spectrum disorder patients. Front Genet 10:434. https://doi.org/10.3389/fgene.2019.00434</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00434</ArticleId><ArticleId IdType="pubmed">31134136</ArticleId><ArticleId IdType="pmc">6517558</ArticleId></ArticleIdList></Reference><Reference><Citation>Mintchev N, Zamba-Papanicolaou E, Kleopa KA, Christodoulou K (2009) A novel ALS2 splice-site mutation in a Cypriot juvenile-onset primary lateral sclerosis family. Neurology 72(1):28&#x2013;32</Citation><ArticleIdList><ArticleId IdType="pubmed">19122027</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saif A, Bohlega S, Al-Mohanna F (2012) Loss of ERLIN2 function leads to juvenile primary lateral sclerosis. Ann Neurol 72(4):510&#x2013;516</Citation><ArticleIdList><ArticleId IdType="pubmed">23109145</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>